NCT06106607

Brief Summary

Emerging research suggests that physical activity may improve health-related quality of life (HrQoL) in patients with inflammatory bowel disease (IBD) and positively influence physical symptoms, fatigue, stress and anxiety. However, little is known about detailed movement patterns and their specific health effects in IBD patients or about patients' wishes, motivation and preferences for physical activity in their everyday lives. Based on exisiting evidence, the investigators' hypothesis is that an individually tailored, behavioural intervention focusing on reducing sedentary behaviour and increasing daily physical activity is feasible and effective in patients with IBD. Therefore, the overall aim of this randomized feasibility study is to determine the feasibility of the behavioural intervention, including the testing of recruitment procedures, intervention adherence, retention and outcome assessments. Intervention participants will undergo:

  • An one-hour individual session with a physiotherapist
  • Being teamed up with 1-2 'exercise buddies' (other intervention participants) and/or
  • Access to four short 2-3 minutes videos/'reels' of a physiotherapist explaining and demonstrating beneficial physical exercises Results from the present feasibility study will determine if and how to proceed with a large-scale randomized controlled trial evaluating the efficacy of the intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 24, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 30, 2023

Completed
16 days until next milestone

Study Start

First participant enrolled

November 15, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 3, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 3, 2024

Completed
Last Updated

January 30, 2025

Status Verified

January 1, 2025

Enrollment Period

10 months

First QC Date

October 24, 2023

Last Update Submit

January 29, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Recruitment

    Recruitment rates will be calculated as the proportion of patients randomised/proportion of patients eligible

    Assessed at 3 months after baseline

  • Retention

    Retention rates will be calculated as the proportion of patients providing the outcomes of interest/proportion of patients randomised

    Assessed at 5 months (20 weeks)

  • Intervention adherence

    Adherence to intervention protocol will be calculated as the number of group and motivational counselling sessions attended out of the total number of sessions available

    Assessed at 5 months (20 weeks)

  • Intervention acceptability

    Acceptability of intervention protocol will be calculated as the number of received optional elements of the intervention out of the total number of optional intervention elements available

    Assessed at 5 months (20 weeks)

Secondary Outcomes (18)

  • Objectively measured physical activity measured by SENS monitor

    Assessed at baseline and at 5 months (20 weeks)

  • Self-reported physical activity and sitting time measured by the Physical Activity Scale (PAS)

    Assessed at baseline and at 5 months (20 weeks)

  • Exercise self-efficacy measured by the Exercise Self-Efficacy Scale

    Assessed at baseline and at 5 months (20 weeks)

  • Health-related quality of life measured by the Inflammatory Bowel Disease Questionnaire (IBDQ)

    Assessed at baseline and at 5 months (20 weeks)

  • Fatigue measured by The Multi-dimensional Fatigue Inventory (MFI-20)

    Assessed at baseline and at 5 months (20 weeks)

  • +13 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

This group will undergo a 20-week individually tailored, behavioral intervention

Behavioral: Intervention group

Control group

NO INTERVENTION

This group will be encouraged to maintain usual lifestyle and activities.

Interventions

A 20-week intervention with a basic part, including 1. A group session with education about IBD,physical activity and exercise in relation to IBD (definitions, evidence and recommendations). Furthermore, access to a video with general information about IBD, physical activity and exercise 2. Four individual motivational counselling sessions (two physical, two by telephone) with a project nurse. These will involve identifying individual motivation and opportunities for increasing physical activity and behavioral goal setting. An optional intervention part will follow, including choises between (or all of) 1. A one-hour individual session with a physiotherapist, involving guidance in physical activity and exercise tailored to the individual. 2. Being teamed up with 1-2 'exercise buddies' (other participants from the overall intervention group). 3. Access to 4 short 2-3 minutes videos/'reels' of a physiotherapist explaining and demonstrating beneficial physical exercises.

Intervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A diagnosis of IBD (Crohn's disease or ulcerative colitis) \> 1 year
  • Over 18 years of age
  • Minimum three months stable medication type and dose without use of steroids as part of the medical treatment during the last three months
  • Speak and understand Danish

You may not qualify if:

  • Unable to give informed consent
  • Active inflammatory disease in joints, skin, pancreas, thyroid, lungs or liver that can hinder engagement in physical activity and exercise
  • Cognitive and/or mental disabilities that can hinder engagement in physical activity and exercise
  • Engaging in high-intensity physical activity -/\> 8 hours pr week

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Digestive Disease Center, BFH

Copenhagen, 2400, Denmark

Location

MeSH Terms

Conditions

Inflammatory Bowel DiseasesMotor ActivitySedentary Behavior

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesBehavior

Study Officials

  • Mette Aadahl, PhD

    Professor at Center for Clinical Research and Prevention

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Allocation status of study participants will not be revealed for the project nurses that conduct the outcome assessments
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
NETWORK
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Postdoc

Study Record Dates

First Submitted

October 24, 2023

First Posted

October 30, 2023

Study Start

November 15, 2023

Primary Completion

September 3, 2024

Study Completion

September 3, 2024

Last Updated

January 30, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

As this is a feasibility study, sharing of outcome data is not relevant

Locations